Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore

被引：0
|
作者：
Hua JS
Bow H
Zheng PY
Khay-Guan Y
机构：
[1] Department of Medicine Faculty of Medicine,National University of Singapore,5,Science Drive 2,Singapore 117597,Republic of Singapore
[2] Department of Microbiology Faculty of Medicine,National University of Singapore,5,Science Drive 2,Singapore 117597,Republic of Singapore
来源：
World Journal of Gastroenterology | 2000年 / 6卷 / 01期
关键词：
Subject headings; Helicobacter pylori; triple therapy; metronidazole; clarithromycin;
D O I：
暂无
中图分类号：
R573 [胃疾病];
学科分类号：
1002 ; 100201 ;
摘要：
INTRODUCTIONEradication of Helicobacter pylori,a bacteriumresiding in stomach and causing peptic ulcer disease,can be achieved by using combination therapiesconsisting of one or two antibiotics with a protonpump inhibitor (PPI).The major antibiotics widelyused in the regimens to eradicate H.pylori aremetronidazole and clarithromycin.However,resistance to these antibiotics by H.pylori affects
引用
收藏
页码：119 / 121
页数：3
相关论文
共 50 条
  • [41] Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain.: A systematic review
    Gisbert, JP
    Pajares, JM
    MEDICINA CLINICA, 2001, 116 (03): : 111 - 116
  • [42] Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori
    Sörberg, M
    Hanberger, H
    Nilsson, M
    Björkman, A
    Nilsson, LE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1222 - 1228
  • [43] Prevalence of Helicobacter pylori clarithromycin resistance in Central Hungary
    Kocsmar, E.
    Buzas, G.
    Kocsmar, I.
    Hritz, I.
    Szijarto, A.
    Lotz, G.
    HELICOBACTER, 2019, 24
  • [44] Prevalence of resistance of Helicobacter pylori to clarithromycin in Santiago, Chile
    Gonzalez-Hormazabal, P.
    Castro, V. G.
    Musleh, M.
    Lanzarini, E.
    Valladares, H.
    Escandar, S.
    Berger, Z.
    HELICOBACTER, 2016, 21 : 102 - 103
  • [45] High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients
    Shetty, Vignesh
    Lamichhane, Binit
    Tay, Chin Yen
    Pai, Ganesh C.
    Lingadakai, Ramachandra
    Balaraju, Girisha
    Shetty, Shiran
    Ballal, Mamatha
    Chua, Eng Guan
    GUT PATHOGENS, 2019, 11 (1)
  • [46] High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients
    Vignesh Shetty
    Binit Lamichhane
    Chin Yen Tay
    Ganesh C. Pai
    Ramachandra Lingadakai
    Girisha Balaraju
    Shiran Shetty
    Mamatha Ballal
    Eng Guan Chua
    Gut Pathogens, 11
  • [47] Primary and secondary resistance to metronidazole and clarithromycin in Spanish Helicobacter pylori clinical isolates obtained from children
    Cibrelus, L.
    Alarcon, T.
    Urruzuno, P.
    Martinez, M.
    De Ayala, A. Perez
    Diaz-Reganon, J.
    Lopez-Brea, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S243 - S243
  • [48] PREVALENCE OF PRIMARY RESISTANCE OF HELICOBACTER PYLORI TO CLARITHROMYCIN (CLA) AND LEVOFLOXACIN (LF) IN SOUTHERN SPAIN
    Navarro-Jarabo, J.
    Fernandez-Sanchez, F.
    Fernandez-Moreno, N.
    Casado, F.
    Hervas, A.
    Pallares, H.
    Rodriguez, C.
    Puente, J.
    Perz-Aisa, A.
    Montiel, N.
    HELICOBACTER, 2013, 18 : 138 - 138
  • [49] Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance:: the HERO study
    Katelaris, PH
    Adamthwaite, D
    Midolo, P
    Yeomans, ND
    Davidson, G
    Lambert, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (06) : 751 - 758
  • [50] Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults
    Peretz, Avi
    Paritsky, Maya
    Nasser, Omar
    Brodsky, Diana
    Glyatman, Tatyana
    Segal, Sofia
    On, Avi
    JOURNAL OF ANTIBIOTICS, 2014, 67 (08): : 555 - 557
12345